Feature Channels:

Vaccines

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

children's hospital of Michigan, Detroit Medical Center, Dr. Lauren Snabb, Pediatricians, National Infant Immunization Week, Vaccinations, Measles, Whooping Cough, Polio

Keep Your Child and the General Public Safe

SnabbLauren9304_pp.JPG

Widely considered one of the greatest medical achievements of modern civilization, vaccines have prevented countless cases of disease and saved millions of lives.

Medicine

Channels:

Antibiotics, COPD, Southampton, Viral Infections, flu

Researchers Develop Novel Flu Test to Speed Up Respiratory Treatment

doctorsandnurses.jpg_SIA_JPG_fit_to_width_INLINE.jpeg

Doctors and researchers in Southampton have developed a novel way of using a swab test which can rapidly diagnose flu and other viral infections in patients with severe respiratory conditions – resulting in shorter courses of antibiotics and less time in hospital.

Medicine

Channels:

Peer Reviewed Publication Confirms the Absence of Rhabdovirus in Cell Line Used for Manufacturing of Flublok®

/PRNewswire/ -- Protein Sciences Corporation is pleased to announce the publication of its manuscript entitled "Complete Study Demonstrating the Absence of Rhabdovirus in a Distinct Spodoptera frugiperda (Sf9) Cell Line" in the peer-reviewed journal PLOS ONE, Volume 12 issue 4. The publication follows extensive testing of the parent cells from which Protein Sciences' proprietary expresSF+® (SF+) cell line is derived. The study confirms that a contaminating rhabdovirus previously reported in a related cell line is not present in SF+ cells. These results demonstrate that not all cell lines are equal even if they are derived from the same parent cell line and highlight the high quality of the SF+ cell lineage.

Medicine

Channels:

HIV, AIDS, Ya Chi Ho, Immune, proviruses

New Evidence: Defective HIV Proviruses Hinder Immune System Response and Cure

HIV_Virus_Blue_iStock_42739584TW.jpg

Researchers at Johns Hopkins and George Washington universities report new evidence that proteins created by defective forms of HIV long previously believed to be harmless actually interact with our immune systems and are actively monitored by a specific type of immune cell, called cytotoxic T cells.

Science

Channels:

Bacillus ACT 2017, Anthrax, Conference, Bacillus Anthracis, Victoria, British Columbia

International Anthrax Conference To Explore Latest Scientific Research Findings

conference875x500px.jpg

Scientists and researchers from all over the world who work on Bacillus anthracis, the causative agent of anthrax, and B. cereus and B. thuringiensis, two closely related bacillus species, will be heading to Victoria, British Columbia, in October for the international conference known as “Bacillus ACT.”

Medicine

Channels:

The "Geneva Signature" Measures the Safety and Efficiency of a Vaccine Against Ebola Virus Disease

The 2014–2015 Ebola epidemic affected several countries in West Africa, leading to the death of more than 11'000 people. Although this epidemic of Ebolavirus disease is over, there is no knowing if, when or where another may strike. It is therefore more important than ever to find a reliable vaccine against this deadly disease. Research on vaccines, which was ongoing during the epidemic in West Africa, is now yielding promising results.

Medicine

Channels:

Could Yellow Fever Rise Again?

BenjaminRush.jpg

Many people might not have heard of the Aedes aegypti mosquito until this past year, when the mosquito, and the disease it can carry – Zika – began to make headlines. But more than 220 years ago, this same breed of mosquito was spreading a different and deadly epidemic right here in Philadelphia and just like Zika, this epidemic is seeing a modern resurgence, with Brazil at its epicenter.

Medicine

Business

Channels:

La Jolla Institute for Allergy and Immunology, Dr. Sette

LJI Research Lab Wins Best Academic Research Team Award

Dr. Alessandro Sette’s team at La Jolla Institute for Allergy and Immunology has been named Best Academic Research Team as part of the 10th Vaccine Industry Excellence Awards at this year’s World Vaccine Congress 2017 held in Washington. The ViE Awards celebrate the outstanding contributions and achievements of leaders who continually set standards of excellence and advocacy in vaccine development.

Medicine

Channels:

Duke Cancer Institute, Duke University Medical Center, Duke University School of Medicine, Glioblastoma, GBM, Glioblastoma Multiforme, Glioblastoma Patients, Brain Cancer Research, brain cancer treatment, brain cancer vaccine , Brain Cancer Therapy, Brain Tumor, Brain Tumor Immunotherapy Program, Brain Tumor Research, Immunotherapy, Chemotheraphy, Phase 1

Immunotherapy for Glioblastoma Well Tolerated; Survival Gains Observed

batich.01.website.jpg

A phase one study of 11 patients with glioblastoma who received injections of an investigational vaccine therapy and an approved chemotherapy showed the combination to be well tolerated while also resulting in unexpectedly significant survival increases, researchers at the Duke Cancer Institute report.

Medicine

Science

Channels:

NIH Award, National Institute On Drug Abuse, HIV, Vaccines, Hiv Vaccine, Jupiter, Palm Beach, Immunology, microbioloby

Scripps Florida Scientist Awarded $4.8 Million to Bring HIV Vaccine Closer to Human Trials

farzan_michael1b_1.jpg

Professor Michael Farzan, co-chair of the Department of Immunology and Microbiology on the Florida campus of The Scripps Research Institute (TSRI) has received $4.8 million in funding through a 2017 Avant-Garde Award for HIV/AIDS research from the National Institutes of Health’s National Institute on Drug Abuse (NIDA). The new funding will support a five-year project, led by Farzan, to bring a potential HIV vaccine closer to human clinical trials.







Chat now!